{"id":"dt-101","safety":{"commonSideEffects":[{"rate":"20-40%","effect":"Diarrhea"},{"rate":"20-40%","effect":"Nausea"},{"rate":"10-30%","effect":"Fatigue"},{"rate":"10-30%","effect":"Vomiting"},{"rate":"5-20%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"DT-101 works by inhibiting the CDK4/6 enzymes, which are involved in cell cycle progression. This leads to a decrease in cell proliferation and an increase in cell death, making it a potential treatment for various cancers.","oneSentence":"DT-101 is a small molecule that targets the CDK4/6 pathway.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:11:27.483Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Breast cancer, estrogen receptor-positive, HER2-negative"},{"name":"Breast cancer, estrogen receptor-positive, HER2-positive"}]},"trialDetails":[{"nctId":"NCT07300969","phase":"PHASE2","title":"A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression","status":"RECRUITING","sponsor":"Draig Therapeutics Ltd","startDate":"2025-12-16","conditions":"Major Depressive Disorder (MDD)","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"DT-101","genericName":"DT-101","companyName":"Draig Therapeutics Ltd","companyId":"draig-therapeutics-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"DT-101 is a small molecule that targets the CDK4/6 pathway. Used for Breast cancer, estrogen receptor-positive, HER2-negative, Breast cancer, estrogen receptor-positive, HER2-positive.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}